278 completed, 66 unknown, 62 recruiting, 38 terminated. 524 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 524 | Completed 278, Unknown 66, Recruiting 62, Terminated 38, Not yet recruiting 35, Withdrawn 22, Active not recruiting 19, Enrolling by invitation 3, Suspended 1 |
Follow Mental Disorders: new trials by email Literature Review of Mental Disorders trials Research Report on Mental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD transcutaneous auricular vagus nerve stimulation, sham transcutaneous auricular vagus nerve stimulation - PTSD - Post Traumatic Stress Disorder | Early Phase 1 | Not yet recruiting | Wayne State University | 60 | 2027-04-01 | 2026-07-13 |
| PTSD and Alcohol Couples Treatment for Veterans COPE + BFIT - PTSD, AUD | Early Phase 1 | Not yet recruiting | VA Office of Research and Development | 80 | 2027-03-01 | 2026-02-10 |
| Research Investigating Drug Effects-2 (RiDE-2) Placebo Oral Capsule, THC - Cannabis Use, Substance Use Disorder (SUD) | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 144 | 2027-01-04 | 2026-10-22 |
| Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream Biospecimen Collection, Cannabis sativa Extract, Nicotine - Cannabis Dependence | Early Phase 1 | Not yet recruiting | Roswell Park Cancer Institute | 60 | 2026-12-15 | 2026-11-16 |
| Addressing Violence in the Context of Opioid Use Disorder Care SHE-OUD - Sexual Violence, Opioid Use Disorder | Early Phase 1 | Not yet recruiting | Lifespan | 20 | 2026-12-05 | 2026-11-17 |
| Examining the Role of Sensitivity to Uncertain Threat and Alcohol Response in Risk for Alcohol Use Disorder Following Sexual Assault in College Women Alcohol, Placebo - Sexual Assault, Alcohol Intoxication | Early Phase 1 | Not yet recruiting | Ohio State University | 220 | 2026-12-01 | 2026-10-26 |
| Cholinergic Enhancement of Theta COBENFY KarXT (50/20 mg), Control - Epilepsy, Seizures | Early Phase 1 | Not yet recruiting | University of Texas Southwestern Medical Center | 50 | 2026-12-01 | 2026-09-29 |
| Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle Dexmedetomidine, Control (placebo) group - Sleep, Delirium | Early Phase 1 | Not yet recruiting | University of Alberta | 50 | 2026-12-01 | 2026-10-13 |
| Kava Aging and Mobility Study AB-free kava, Placebo - Old Adults, Sleep Quality | Early Phase 1 | Not yet recruiting | University of Florida | 40 | 2026-12-01 | 2026-08-31 |
| Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis Cannabis (THC), Tobacco Cigarette - Cannabis Use, Tobacco | Early Phase 1 | Not yet recruiting | Hannah Harris | 12 | 2026-12-01 | 2026-11-04 |
| reALIGNing Circadian Rhythm and Promoting Sleep in the Intensive Care Unit Sleep chronobundle, Control - Sleep, Circadian Dysregulation | Early Phase 1 | Not yet recruiting | University of Alberta | 50 | 2026-11-30 | 2026-10-21 |
| Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial Guanfacine (GFC), Cromolyn Sodium, Placebo - Postural Orthostatic Tachycardia Syndrome (POTS), Dysautonomia | Early Phase 1 | Not yet recruiting | Johns Hopkins University | 25 | 2026-11-20 | 2026-11-12 |
| Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use Disorder Alcohol, Placebo - Opioid Use Disorder, Alcohol Intoxication | Early Phase 1 | Not yet recruiting | Ohio State University | 90 | 2026-11-01 | 2026-10-26 |
| Predictors & Mechanisms of Adolescent PTSD Repeated imaginal exposure: Script Driven Imagery (SDI) task - Posttraumatic Stress Disorder (PTSD), Trauma Exposure | Early Phase 1 | Not yet recruiting | Medical University of South Carolina | 180 | 2026-11-01 | 2026-10-09 |
| Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department Haloperidol - Cannabinoid Hyperemesis Syndrome | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 100 | 2026-11-01 | 2026-09-01 |
| Aprepitant for the Treatment of CLIFAHDD Aprepitant Powder for Oral Suspension - CLIFAHDD, Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 5 | 2026-10-31 | 2026-11-05 |
| A Web-based Intervention Program for Postpartum Depression Web-based program for postpartum depression - Postpartum Depression (PPD), Web-based Intervention | Early Phase 1 | Recruiting | Babes-Bolyai University | 30 | 2026-10-27 | 2026-10-28 |
| Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants Placebo, MCAM - Opioid Use Disorder | Early Phase 1 | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 24 | 2026-10-22 | 2026-10-05 |
| Individualized (fMRI-guided) TMS Intervention for Post-Traumatic Stress Disorder (PTSD) Active Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS) - PTSD, Post Traumatic Stress Disorder (PTSD) | Early Phase 1 | Not yet recruiting | University of Pennsylvania | 60 | 2026-10-12 | 2026-08-31 |
| Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking CONNECT - Sex Trafficking, HIV | Early Phase 1 | Not yet recruiting | Lifespan | 60 | 2026-10-05 | 2026-07-13 |
Showing 20 of 524. Sign in to see all of them.
Alzheimer Disease (63) · Anxiety Disorders (41) · Stress Disorders, Post-Traumatic (40) · Depression (37) · Cognitive Dysfunction (34) · Opioid-Related Disorders (33) · Alcoholism (30) · Marijuana Abuse (29) · Depressive Disorder, Major (28) · Schizophrenia (27) · Tobacco Use Disorder (27) · Substance-Related Disorders (24) · Psychotic Disorders (21) · Attention Deficit Disorder with Hyperactivity (18) · Sleep Initiation and Maintenance Disorders (18)
Nervous System Diseases (159) · Chemically-Induced Disorders (151) · Neurocognitive Disorders (130) · Substance-Related Disorders (127) · Pathological Conditions, Signs and Symptoms (102) · Central Nervous System Diseases (99) · Behavior (97) · Brain Diseases (96) · Signs and Symptoms (91) · Neurodegenerative Diseases (79) · Neurologic Manifestations (74) · Dementia (72) · Tauopathies (61) · Behavioral Symptoms (49)
Dronabinol (21) · Ketamine (19) · Nicotine (14) · Acetylcysteine (11) · Dexmedetomidine (10) · nabiximols (10) · Cannabidiol (9) · Ethanol (9) · Oxytocin (9) · Methylphenidate (8) · Cycloserine (7) · Psilocybin (7) · Sodium Chloride (7) · Cognitive Behavioral Therapy (6) · Deep Brain Stimulation (6)
Yale University (37) · Medical University of South Carolina (11) · University of California, San Francisco (11) · University of California, San Diego (9) · Johns Hopkins University (7) · Massachusetts General Hospital (7) · Mclean Hospital (7) · The University of Texas Health Science Center at San Antonio (7) · University of Pennsylvania (7) · Beijing Pins Medical Co., Ltd (5) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (5) · University of California, Los Angeles (5) · University of Minnesota (5) · VA Office of Research and Development (5) · Avid Radiopharmaceuticals (4)
United States (351) · China (25) · Canada (22) · United Kingdom (15) · Sweden (7) · Belgium (6) · Denmark (6) · Egypt (6) · Netherlands (6) · Australia (5) · Israel (5) · France (4) · Germany (4) · Spain (4) · Norway (3)
Li Luming, PhD (5) · Danna Jennings, MD (4) · Dawson Church, PhD (4) · Josh D Woolley, MD/PhD (4) · Colleen A Hanlon, PhD (3) · Mehmet Sofuoglu, M.D.,Ph.D. (3) · Michael Segal, MD PhD (3) · Andrea Reinecke, PhD (2) · Bradley C Lega, MD (2) · Christopher P Cardozo, MD (2) · Cristina Sampaio, MD, PhD (2) · Dardo G Tomasi, Ph.D. (2)
PMID 28642081, PMID 11143733, PMID 15474895, PMID 15931222, PMID 16677714, PMID 18174562, PMID 18426576, PMID 18984559, PMID 20097391, PMID 20501908, PMID 21176784, PMID 21569488, PMID 22246119, PMID 22459048, PMID 22581070, PMID 22654774, PMID 22905331, PMID 23134619, PMID 23438090, PMID 23481118, PMID 23763450, PMID 24006963, PMID 24761279, PMID 24938135, PMID 25182079, PMID 25276687, PMID 25447751, PMID 25581657, PMID 25885697, PMID 25948052, PMID 26111923, PMID 26158265, PMID 26203461, PMID 26364274, PMID 26619358, PMID 27137199, PMID 27206648, PMID 27520015, PMID 27575343, PMID 27763627, PMID 27814297, PMID 27869829, PMID 27909164, PMID 27918562, PMID 28521048, PMID 28551715, PMID 28709450, PMID 28789647, PMID 28849779, PMID 29282327
K01DA039299 (2), K12DA031794 (2), R01AA025247 (2), R01DA047368 (2), R35GM146822 (2), 1UG3HL161342-01A1 (1), 2018 (1), I01RX000825 (1), IK2RD000536 (1), K01DA043652 (1), K01DA046561 (1), K01DA056692 (1), K01MH109871 (1), K05AA014715 (1), K23AA030355 (1)